Group One Trading, L.P. Grifols Sa Transaction History

Group One Trading, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.27 - $7.7 $7,636 - $9,378	1,218 Added 0.53%	230,735 $1.45 Million
Q1 2024 May 10, 2024	BUY	$5.47 - $11.38 $1.26 Million - $2.61 Million	229,517 New	229,517 $1.53 Million
Q2 2023 Aug 09, 2023	BUY	$7.14 - $9.29 $8,189 - $10,655	1,147 Added 5.22%	23,124 $211,000
Q1 2023 May 12, 2023	BUY	$6.65 - $10.69 $114,200 - $183,579	17,173 Added 357.47%	21,977 $161,000
Q4 2022 Feb 09, 2023	SELL	$5.96 - $8.53 $35,164 - $50,326	-5,900 Reduced 55.12%	4,804 $40,000
Q3 2022 Nov 09, 2022	BUY	$5.95 - $14.3 $63,688 - $153,067	10,704 New	10,704 $66,000
Q2 2022 Aug 11, 2022	SELL	$10.6 - $13.28 $2,925 - $3,665	-276 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$10.37 - $12.73 $7,507 - $9,216	-724 Reduced 72.4%	276 $3,000
Q4 2021 Feb 11, 2022	BUY	$10.21 - $15.27 $10,210 - $15,270	1,000 New	1,000 $11,000
Q3 2017 Nov 15, 2017	SELL	$20.07 - $21.89 $5,017 - $5,472	-250 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	250	250 $5,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.